Occurrence of non-Hodgkin's lymphoma after therapy for Hodgkin's disease.

We studied the clinical and pathological features of six cases of non-Hodgkin's lymphoma (diffuse undifferentiated in four cases and diffuse histiocytic in two cases) occuring in patients treated for Hodgkin's disease. All six patients had received both radiation and chemotherapy. Abdominal or gastrointestinal involvement was present in five of the six cases. None of the patients had evidence of Hodgkin's disease when the diagnosis of non-Hodgkin's lymphoma was made. Five of the six patients were among a study group of 579 patients with Hodgkin's disease, prospectively followed since diagnosis. At 10 years the actuarial risk of development of non-Hodgkin's lymphoma in this study group is 4.4 per cent (1.2 to 15.0) (per cent probability with 95 per cent confidence limits) and is similar to that of developing acute leukemia: 2.0 per cent (0.3 to 12.9). Non-Hodgkin's lymphoma is a second tumor that may occur late in the course of patients treated for Hodgkin's disease--particularly in patients who have received both radiation therapy and chemotherapy. Like acute leukemia, non-Hodgkin's lymphoma may be another cancer that represents a substantial late risk of combined-modality therapy.

[1]  E. Glatstein,et al.  Combined modality therapy of Hodgkin's disease. A report on the stanford trials , 1978, Cancer.

[2]  R. Levy,et al.  Immunopathology of follicular lymphomas. A model of B-lymphocyte homing. , 1978, The New England journal of medicine.

[3]  E. Glatstein,et al.  Hematologic neoplasia in patients treated for Hodgkin's disease. , 1977, The New England journal of medicine.

[4]  D. Purtilo,et al.  Variable phenotypic expression of an X-linked recessive lymphoproliferative syndrome. , 1977, The New England journal of medicine.

[5]  V. Devita,et al.  Risk of new cancers in patients with Hodgkin's disease , 1977, Cancer.

[6]  D. Schottenfeld,et al.  Multiple primary cancer risk after therapy for Hodgkin's disease , 1977, Cancer.

[7]  Purtilo Dt.  Opportunistic non-Hodgkin's lymphoma in X-linked recessive immunodeficiency and lymphoproliferative syndromes. , 1977 .

[8]  J. Bertino,et al.  Acute nonlymphocytic leukemia. A delayed complication of Hodgkin's disease therapy: Analysis of 109 cases , 1977, Cancer.

[9]  R. Hoover,et al.  Acute leukemia after alkylating-agent therapy of ovarian cancer. , 1977, The New England journal of medicine.

[10]  P. Revell,et al.  The simultaneous presentation of Hodgkin's disease of myeloma. , 1977, Postgraduate medical journal.

[11]  J. Rosai,et al.  Post-transplant malignant lymphoma. Distinctive morphologic features related to its pathogenesis. , 1976, The American journal of medicine.

[12]  V. Devita,et al.  Bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP) combination chemotherapy in the treatment of advanced diffuse histiocytic lymphoma. , 1976, Annals of internal medicine.

[13]  E. Jaffe,et al.  Non-endemic Burkitts's lymphoma. A B-cell tumor related to germinal centers. , 1976, The New England journal of medicine.

[14]  M. Tavassoli,et al.  Simultaneous occurrence of myeloma and Hodgkin's disease. , 1976, Acta haematologica.

[15]  A. Papaioannou.  SECOND MALIGNANCIES IN TREATED HODGKIN'S PATIENTS AND SPLENECTOMY , 1975, The Lancet.

[16]  J. Whang‐Peng,et al.  SECOND MALIGNANCIES COMPLICATING HODGKIN'S DISEASE IN REMISSION , 1975, The Lancet.

[17]  F. Rosner,et al.  Hodgkin's disease and acute leukemia. Report of eight cases and review of the literature. , 1975, The American journal of medicine.

[18]  R. Lukes,et al.  Immunologic characterization of human malignant lymphomas , 1974, Cancer.

[19]  R. Dorfman,et al.  Morphological studies of 84 untreated patients subjected to laparotomy for the staging of non‐Hodgkin's lymphomas , 1974, Cancer.

[20]  J. Costanzi,et al.  Conversion of Hodgkin's disease to lymphoblastic lymphosarcoma. , 1974, Oncology.

[21]  M. Moore,et al.  Sequential radiotherapy and chemotherapy in the treatment of Hodgkin's disease. A progress report. , 1972, Annals of internal medicine.

[22]  R. Lukes.  Criteria for involvement of lymph node, bone marrow, spleen, and liver in Hodgkin's disease. , 1971, Cancer research.

[23]  M Tubiana,et al.  Report of the Committee on Hodgkin's Disease Staging Classification. , 1971, Cancer research.

[24]  V. Devita,et al.  Combination chemotherapy in the treatment of advanced Hodgkin's disease. , 1970, Annals of internal medicine.

[25]  G. O'Conor,et al.  Persistent immunologic stimulation as a factor in oncogenesis, with special reference to Burkitt's tumor , 1970 .

[26]  D. Whitelaw.  Multiple primary carcinomas associated with Hodgkin's disease. , 1968, Canadian Medical Association journal.

[27]  J. Berg.  The incidence of multiple primary cancers. I. Development of further cancers in patients with lymphomas, leukemias, and myeloma. , 1967, Journal of the National Cancer Institute.

[28]  L. Craver,et al.  Hodgkin's disease associated with other malignant tumors and certain non-neoplastic diseases. , 1959, The American journal of the medical sciences.

[29]  C. Moertel,et al.  Leukemia or lymphoma and coexistent primary malignant lesions: a review of the literature and a study of 120 cases. , 1957, Blood.